Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine enhancement of exposure therapy in panic disorder with agoraphobia
2010-021198-35Phase 3Completed
- Sponsor
- Utrecht University
- Start
- Aug 2010
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of d-cycloserine in Agoraphobia with panic disorder (PD/A) (3 arms), sponsored by Utrecht University. Primary endpoint: Panic Disorder Severity Scale. Started Aug 2010; status: completed.
02
Drugs
d-cycloserine
03
Conditions
Agoraphobia with panic disorder (PD/A)
Beyond the preview
Go deeper on 2010-021198-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021198-35.